Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

MediWound (MDWD) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for MediWound (MDWD) over the last 13 years, with Q2 2025 value amounting to $429000.0.

  • MediWound's Interest & Investment Income fell 2628.87% to $429000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $7.3 million, marking a year-over-year increase of 478.04%. This contributed to the annual value of $2.0 million for FY2024, which is 8077.18% down from last year.
  • Per MediWound's latest filing, its Interest & Investment Income stood at $429000.0 for Q2 2025, which was down 2628.87% from $582000.0 recorded in Q2 2024.
  • Over the past 5 years, MediWound's Interest & Investment Income peaked at $5.8 million during Q2 2023, and registered a low of -$635000.0 during Q4 2021.
  • In the last 5 years, MediWound's Interest & Investment Income had a median value of $128500.0 in 2021 and averaged $701800.0.
  • In the last 5 years, MediWound's Interest & Investment Income plummeted by 19665.14% in 2021 and then skyrocketed by 5288181.82% in 2023.
  • Quarter analysis of 5 years shows MediWound's Interest & Investment Income stood at -$635000.0 in 2021, then soared by 168.98% to $438000.0 in 2022, then surged by 1230.59% to $5.8 million in 2023, then crashed by 90.01% to $582000.0 in 2024, then decreased by 26.29% to $429000.0 in 2025.
  • Its last three reported values are $429000.0 in Q2 2025, $582000.0 for Q2 2024, and $5.8 million during Q2 2023.